Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5609962 | Journal of the American Society of Echocardiography | 2013 | 6 Pages |
Abstract
GLS is an independent early predictor of later reductions in EF, incremental to usual predictors in patients at risk for trastuzumab-induced cardiotoxicity.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Kazuaki MD, PhD, Tomoko MD, James L. MBBS, PhD, Brian A. PhD, Juan Carlos MD, Thomas H. MBBS, PhD, MPH,